Listen to Roswellness Radio any time you want. The shows, originally broadcast on WBEN (930 AM/107.7 FM), feature interviews with Roswell Park clinicians and researchers about the latest in cancer research, treatment, prevention and survivorship issues. Listen to or download podcasts of archived shows.
With a cancer diagnosis and its therapy, multiple issues come to play in relation to quality of life. Roswell Park has recently introduced a pilot program to its pediatric cancer patients, as well as their caregivers and family members. The Healing Touch Pilot Program consists of eight two-hour training classes held at Roswell Park over a four-month period. The goal of the program is to help relieve the symptoms of cancer treatment at any stage of the cancer journey.
Listen in as Lynda Kwon Beaupin, MD, Assistant Professor of Oncology describes how this safe energy medicine modality can complement conventional medicine. You’ll also hear from Suzanne Hess, PhD, CHTP, Grant Coordinator and Co-Director of the Healing Touch Pilot Program. Dr. Hess is a Certified Healing Touch Practitioner who has more than nine years of experience and more than 300 hours of formal training.
Teresa O’Connor joins Drs. Beaupin and Hess, sharing thoughts on her experiences in the pilot program with her eight-year-old daughter, Molly, who was diagnosed with Langerhans cell histiocytosis in February 2012. Molly recently completed chemotherapy treatment and enjoys attending the training classes with her mom and bringing what she learns home to her dad and sisters.
Roswellness Radio: Cancer Research in the Genomic Era, with Dr. Morrison, Dr. Sabatini and K. Johnson Hoffman
Cancer survivor Katie Johnson Hoffman joins Carl Morrison, MD, DVM, and Linda Sabatini, PhD, for a discussion on how national initiatives in genetic research and advances in the field of personalized medicine are improving the outlook for cancer patients.
Dr. Morrison is Clinical Chief of the RPCI Department of Pathology & Laboratory Medicine, Director of Molecular Pathology and Director of the Pathology Resource Network.
Dr. Roberto Pili, Chief of the Genitourinary Section and Co-leader of the Genitourinary Program at RPCI, talks about Provenge, the first FDA-approved vaccine for the treatment of cancer. Joined by prostate-cancer survivor Russell Even, he talks about this drug, also known as sipuleucel-T, a new treatment option for some men with advanced prostate cancer.
Jonathan Olsen, Campus Planning Chair, team captain Bill Wallace and Ride Manager Lisa Scherer stopped by WBEN's studios to talk about all things Ride for Roswell: basic information, the rider experience, what's new this year and what Roswell Park does with money raised through this 16-year-old fundraising effort.
Ride For Roswell rider and fundraiser John Hannon joins Lee Wortham, Chair of the Roswell Park Alliance Foundation, and The Ride For Roswell's Sally Russell for a conversation about two major programs to raise funds for RPCI cancer care and research – one longstanding and one brand-new.
On April 6, 2011, four RPCI clinicians and researchers gathered at Roswell Park's Amherst Center to talk about advances in cancer research and treatment over the decades and to answer questions from community members. Here in this two-part series, we present excerpts from that exchange, which featured comments by Candace Johnson, PhD, Deputy Director, Chair of the Department of Pharmacology and Therapeutics and Wallace Chair in Translational Research; Myron Czuczman, MD, Chief of the Lymphoma/Myeloma Service and Head of the Lymphoma Translational Research Laboratory; Willie Underwood III, MD, MPH, MSci, Assistant Professor in the Department of Urology and Assistant Professor in the Office of Cancer Health Disparities Research; and Linda Sabatini, PhD, Director of Molecular Pathology Research and Development and Associate Professor of Oncology.